- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis ; volume:14 ; number:1 ; day:3 ; month:4 ; year:2024 ; pages:1-11 ; date:12.2024
Scientific reports ; 14, Heft 1 (3.4.2024), 1-11, 12.2024
- Urheber
-
Yamada, Kayoko
Takeuchi, Masaki
Fukumoto, Takeshi
Suzuki, Minako
Kato, Ai
Mizuki, Yuki
Yamada, Norihiro
Kaneko, Takeshi
Mizuki, Nobuhisa
Horita, Nobuyuki
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-55675-5
- URN
-
urn:nbn:de:101:1-2406190934413.321010764793
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yamada, Kayoko
- Takeuchi, Masaki
- Fukumoto, Takeshi
- Suzuki, Minako
- Kato, Ai
- Mizuki, Yuki
- Yamada, Norihiro
- Kaneko, Takeshi
- Mizuki, Nobuhisa
- Horita, Nobuyuki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Novel treatment paradigms for metastatic uveal melanoma
Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma
The immune cell landscape of metastatic uveal melanoma correlates with overall survival
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Immune checkpoint blockade for metastatic uveal melanoma: patterns of response and survival according to the presence of hepatic and extrahepatic metastasis
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Novel treatment paradigms for metastatic uveal melanoma
Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma
The immune cell landscape of metastatic uveal melanoma correlates with overall survival
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Immune checkpoint blockade for metastatic uveal melanoma: patterns of response and survival according to the presence of hepatic and extrahepatic metastasis
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Novel treatment paradigms for metastatic uveal melanoma
Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma
The immune cell landscape of metastatic uveal melanoma correlates with overall survival
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Immune checkpoint blockade for metastatic uveal melanoma: patterns of response and survival according to the presence of hepatic and extrahepatic metastasis